The role of antithrombin in patients with toxic epidermal necrolysis
| Authors | |
|---|---|
| Year of publication | 2017 |
| Type | Article in Periodical |
| Magazine / Source | Burns |
| MU Faculty or unit | |
| Citation | |
| Doi | http://dx.doi.org/10.1016/j.burns.2017.01.031 |
| Field | Surgery incl. transplantology |
| Keywords | antithrombin |
| Description | Toxic epidermal necrolysis (TEN) is a rare systemic disease, which is predominantly manifested in the skin and mucous membranes. Its indicated incidence in the population is 0.5–1.5 cases per million inhabitants a year. It is the most severe syndrome from the SCARs group (Severe Cutaneous Adverse Reactions) with mortality around 30–50%. |